Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Pituitary ; 18(6): 803-7, 2015 Dec.
Article in English | MEDLINE | ID: mdl-25893613

ABSTRACT

CONTEXT: Acromegaly is a rare disease with complications and increased mortality. The incidence and prevalence of acromegaly worldwide is not well known. OBJECTIVE: To gather information on patients diagnosed with acromegly in Iceland over 59 years. DESIGN: Information was retrospectively gathered about patients diagnosed with acromegaly from 1955 through 2013. Incidence was calculated from the total Icelandic population. SETTING/PATIENTS: Information was gathered from medical records at Landspitali National University Hospital, Iceland, housing the only endocrine department in the country, at the largest hospital outside of Reykjavik (Sjúkrahúsið á Akureyri, Akureyri Hospital) and the largest private outpatient clinic in Reykjavik, where some of the patients received follow-up care. Further, information on patients were sought from all endocrinologists treating adult patients in Iceland. All patients diagnosed with acromegaly during the study period were included. RESULTS: Fifty-two patients (32 men) were diagnosed during the study period. The average age at diagnosis was 44.5 years. Nine patients had died. Symptoms had been present for more than 3 years in most cases. Twenty-five patients had hypertension (48 %). Follow up information was available for 48 patients, 63 % were considered cured after treatment. CONCLUSIONS: The incidence of acromegaly in Iceland during the study period was much higher than earlier reports have indicated. During the last 9 years of the study 7.7 patients were diagnosed per million per year. At diagnosis, 38 % had developed hypertension and 10 % were diagnosed during follow up. This indicates the importance of endocrine disorders in the aetiology of hypertension.


Subject(s)
Acromegaly/epidemiology , Acromegaly/complications , Adult , Female , Humans , Hypertension/epidemiology , Hypertension/etiology , Iceland , Incidence , Male , Middle Aged , Pituitary Neoplasms/complications , Pituitary Neoplasms/epidemiology , Prevalence , Retrospective Studies
2.
Pituitary ; 16(1): 46-55, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22961634

ABSTRACT

A craniopharyngioma (CP) is an embryonic malformation of the sellar and parasellar region. The annual incidence is 0.5-2.0 cases/million/year and approximately 60 % of CP are seen in adulthood. Craniopharyngiomas have the highest mortality of all pituitary tumors. Typical initial manifestations at diagnosis in adults are visual disturbances, hypopituitarism and symptoms of elevated intracranial pressure. The long-term morbidity is substantial with hypopituitarism, increased cardiovascular risk, hypothalamic damage, visual and neurological deficits, reduced bone health, and reduction in quality of life and cognitive function. Therapy of choice is surgery, followed by cranial radiotherapy in about half of the patients. The standardised overall mortality rate varies 2.88-9.28 in cohort studies. Patients with CP have a 3-19 fold higher cardiovascular mortality in comparison to the general population. Women with CP have an even higher risk.


Subject(s)
Craniopharyngioma/mortality , Craniopharyngioma/pathology , Adult , Craniopharyngioma/radiotherapy , Female , Humans , Hypopituitarism/mortality , Hypopituitarism/pathology , Hypopituitarism/radiotherapy , Male
3.
Laeknabladid ; 98(6): 341-6, 2012 06.
Article in Icelandic | MEDLINE | ID: mdl-22647441

ABSTRACT

OBJECTIVE: Venous thromboembolic disease is a serious and often fatal complication following hospital admission. Studies show that thromboprophylactic therapy for this condition is often underutilized. The aim of this study was to evaluate the performance of thromboprophylactic therapy at Landspítali - The University Hospital of Iceland in adult patients admitted to acute wards. METHODS AND MATERIALS: On 2 December 2009 hospital charts of admitted patients on acute wards were reviewed and assessed for appropriate thromboprophylactic treatment according to the 2008 guidelines from The American College of Chest Physicians. The results were compared to those of other countries from the multinational Endorse study from 2008. RESULTS: 251 patient were included of whom 47% were considered at risk for venous thromboembolic disease. Of those 57% received appropriate thromboprophylactic treatment or 78% of surgical and 26% of medical patients. CONCLUSIONS: Adherence to clinical guidelines for thromboprophylactic treatment at surgical wards of Landspítali - The National University Hospital of Iceland was good and well above the average compared to the results of the Endorse study. Performance on the medical wards was on the other hand below average. Our results show that application of thromoboprophylactic treatment at Landspítali could be improved and thereby enhance patient safety.


Subject(s)
Fibrinolytic Agents/administration & dosage , Hospitals, University , Practice Patterns, Physicians' , Venous Thromboembolism/prevention & control , Adult , Aged , Aged, 80 and over , Cross-Sectional Studies , Female , Guideline Adherence , Hospital Units , Hospitals, University/standards , Humans , Iceland , Male , Middle Aged , Patient Safety , Practice Guidelines as Topic , Practice Patterns, Physicians'/standards , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...